Quantitative Model for Efficient Temporal Targeting of Tumor Cells and Neovasculature
The combination of cytotoxic therapies and antiangiogenic agents is emerging as a most promising strategy in the treatment of malignant tumors. However, the timing and sequencing of these treatments seem to play essential roles in achieving a synergic outcome. Using a mathematical modeling approach...
Main Authors: | Kohandel, Mohammad (Author), Haselwandter, Christoph A. (Contributor), Kardar, Mehran (Contributor), Sengupta, S. (Author), Sivaloganathan, S. (Author) |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Physics (Contributor) |
Format: | Article |
Language: | English |
Published: |
Hindawi Pub. Corp.,
2011-08-11T14:17:28Z.
|
Subjects: | |
Online Access: | Get fulltext |
Similar Items
-
Quantitative Model for Efficient Temporal Targeting of Tumor Cells and Neovasculature
by: M. Kohandel, et al.
Published: (2011-01-01) -
Extracellular Vesicles Are Key Regulators of Tumor Neovasculature
by: Naoya Kuriyama, et al.
Published: (2020-12-01) -
Safe eradication of large established tumors using neovasculature‐targeted tumor necrosis factor‐based therapies
by: Leander Huyghe, et al.
Published: (2020-02-01) -
Signaling through Raf-1 in the Neovasculature and Target Validation by Nanoparticles
by: Wary Kishore K
Published: (2003-07-01) -
Targeting of Tumor Neovasculature with GrB/VEGF121, a Novel Cytotoxic Fusion Protein
by: Khalid A. Mohamedali, et al.
Published: (2017-07-01)